EDGAR Filing Documents for 0000950114-96-000171

Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:

SEC Accession No. 0000950114-96-000171

Filing Date

1996-07-15

Accepted

1996-07-15 00:00:00

Documents

Period of Report

1996-03-31

SROs

AMEX

Document Format Files

Seq	Description	Document	Type	Size
1	KV PHARMACEUTICAL CO. FORM 10-K		10-K405	149150
2	AMENDMENT OF CERTIFICATE OF INCORPORATION		EX-3.(E)	2710
3	AMENDMENT OF CERTIFICATE OF INCORPORATION		EX-3.(F)	6080
4	AMENDMENT TO BY-LAWS		EX-3.(H)	2768
5	FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT		EX-4.(S)	8469
6	AMENDED AND RESTATED 1991 INCENTIVE STOCK OPTION PLAN		EX-10.(Y)	27591
7	COMMON STOCK PURCHASE OPTION		EX-10.(Z)	34482
8	THIRD AMENDMENT TO EMPLOY. AGR. WITH MARC HERMELIN		EX-10.(AA)	1963
9	STOCK OPTION AGREEMENT		EX-10.(BB)	16813
10	COMPUTATION OF PER SHARE EARNINGS		EX-11.(A)	4443
11	LIST OF SUBSIDIARIES		EX-22.(A)	506
12	CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS		EX-23.(A)	691
13	FINANCIAL DATA SCHEDULE		EX-27	2065
	Complete submission text file	0000950114-96-000171.txt		260559

Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144

Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600

KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)